BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2242 related articles for article (PubMed ID: 16097768)

  • 1. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorophore-labeled beta-lactamase as a biosensor for beta-lactam antibiotics: a study of the biosensing process.
    Chan PH; So PK; Ma DL; Zhao Y; Lai TS; Chung WH; Chan KC; Yiu KF; Chan HW; Siu FM; Tsang CW; Leung YC; Wong KY
    J Am Chem Soc; 2008 May; 130(20):6351-61. PubMed ID: 18429614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Amp C β-lactamase as a fluorescent screening tool for class C β-lactamase inhibitors.
    Tsang MW; Chan PH; So PK; Ma DL; Tsang CW; Wong KY; Leung YC
    Anal Chem; 2011 Mar; 83(6):1996-2004. PubMed ID: 21338058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of a novel fluorescent biosensor for beta-lactam antibiotics from a class A beta-lactamase.
    Chan PH; Liu HB; Chen YW; Chan KC; Tsang CW; Leung YC; Wong KY
    J Am Chem Soc; 2004 Apr; 126(13):4074-5. PubMed ID: 15053574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
    Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O
    Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
    Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
    Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermostable β-Lactamase Mutant with Its Active Site Conjugated with Fluorescein for Efficient β-Lactam Antibiotic Detection.
    Au HW; Tsang MW; So PK; Wong KY; Leung YC
    ACS Omega; 2019 Dec; 4(24):20493-20502. PubMed ID: 31858033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
    Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
    Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis.
    Oefner C; D'Arcy A; Daly JJ; Gubernator K; Charnas RL; Heinze I; Hubschwerlen C; Winkler FK
    Nature; 1990 Jan; 343(6255):284-8. PubMed ID: 2300174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
    Richmond MH
    Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
    Kumar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies of the mechanism for biosensing antibiotics in a fluorescein-labeled β-lactamase.
    Wong WT; Au HW; Yap HK; Leung YC; Wong KY; Zhao Y
    BMC Struct Biol; 2011 Mar; 11():15. PubMed ID: 21443768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
    Scioli C; Esposito S; Martinelli R
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining an extended-spectrum beta-lactamase.
    Livermore DM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():3-10. PubMed ID: 18154524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of bacterial resistance to beta-lactams by beta-lactamases].
    Sawai T
    Nihon Rinsho; 1997 May; 55(5):1225-30. PubMed ID: 9155179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
    Bedenić B
    Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 113.